Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiority trial

The Lancet Global Health · Published 2026-07-01 · DOI 10.1016/j.langlo.2026.103971

Free full text

Authors (33)

Samyra R Cox, Abhay Kadam, Shahanara Valawalkar, Gayatri Lele, Aye Hnin Moe, Vipul Dhamale, Akshay N Gupte, Nishi Suryavanshi, Emily A Kendall, Hojoon Sohn, Christopher J Hoffmann, Arjunlal Kakrani, Ryan Thompson, Nikhil Gupte, Madhu Sudan Barthwal, Jonathan E Golub, Vidya Mave, Anita Mahajan, Yogash Bhosale, Swati Duga, Pallavi Kadam, Shankar Jadhav, Vaibhavi Bodhe, Pramod Bhalchim, Sachin Rathod, Avanti Patil, Neha Sonawane, Akshay Bhalchim, Anand Patole, Prashant Kulkarni, Rechel Shrisunder, Wasunkar Shreeya, Donghoon Kim

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Cox, S., Kadam, A., Valawalkar, S., et al. (2026). Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiority trial. The Lancet Global Health. https://doi.org/10.1016/j.langlo.2026.103971

Related articles